Vectus Biosystems (ASX:VBS) FCF Margin %: 0.00% (As of Dec. 2025)


ASX:VBS Vectus Biosystems Ltd ASX:VBS
18 GF Score
Price A$0.16
! 2 Warning Signs
View Full Analysis

What is Vectus Biosystems FCF Margin %?

Vectus Biosystems ASX:VBS +3.23% 18 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates ASX:VBS with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 950 Biotechnology companies, Vectus Biosystems ranks worse than 105263.05% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vectus Biosystems's Free Cash Flow for the six months ended in Dec. 2025 was A$-0.17 Mil. Vectus Biosystems's Revenue for the six months ended in Dec. 2025 was A$0.00 Mil. Therefore, Vectus Biosystems's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Vectus Biosystems's current FCF Yield % is -8.41%.

The historical rank and industry rank for Vectus Biosystems's FCF Margin % or its related term are showing as below:


During the past 10 years, the highest FCF Margin % of Vectus Biosystems was -65533.33%. The lowest was -65533.33%. And the median was -65533.33%.

ASX:VBS's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.535
* Ranked among companies with meaningful FCF Margin % only.

Vectus Biosystems FCF Margin % Related Terms

Vectus Biosystems FCF Margin % Historical Data

* Premium members only.

The historical data trend for Vectus Biosystems's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vectus Biosystems FCF Margin % Chart

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -86,200.00 0.00 0.00 0.00 0.00

ASX:VBS vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Vectus Biosystems's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vectus Biosystems FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's FCF Margin % falls into.


ASX:VBS
18GF Score
Vectus Biosystems Ltd ASX:VBS
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vectus Biosystems FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vectus Biosystems's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-0.83/0
= %

Vectus Biosystems's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.17/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Vectus Biosystems (ASX:VBS) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vectus Biosystems and its competitors. According to the industry distribution chart, Vectus Biosystems ranks #999999 out of 950 companies in the Biotechnology industry.
Is Vectus Biosystems' FCF Margin % too high?
Vectus Biosystems' current FCF Margin % is 0.00%. Based on the distribution chart, Vectus Biosystems ranks #999999 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Vectus Biosystems has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Vectus Biosystems' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Vectus Biosystems ranks #999999 out of 950 companies for FCF Margin %. This places Vectus Biosystems in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vectus Biosystems and its competitors. Vectus Biosystems's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vectus Biosystems stock overvalued right now?
Vectus Biosystems (ASX:VBS) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Vectus Biosystems' overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Vectus Biosystems (ASX:VBS), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vectus Biosystems Business Description

Address 26-34 Dunning Avenue, Unit 5, Ground Floor, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic fibrosis, including heart, kidney, liver, and lung fibrosis. Its drug candidate VB0004, is aimed at inhibiting and reversing the loss of functional tissue due to fibrosis, is in its human trials phase.
18GF Score

Get the complete analysis for ASX:VBS

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.16
Price